Stephan Bart

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 342 citations

Veterinary Medicine, Immunology, Infectious Diseases +13

Efficacy and Safety of an Ad26.RSV.preF–RSV preF Protein Vaccine in Older Adults

Ann R. Falsey, Kristi L. Williams, Efi Gymnopoulou et al. · New England Journal of Medicine · 2023 · 146 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Cell Culture–Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults

Stephan Bart, Matthew Hohenboken, Giovanni Della Cioppa et al. · Science Translational Medicine · 2014 · 92 citations

Veterinary Medicine, Immunology, Infectious Diseases +14

A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant

Judith Falloon, Fei Ji, Craig Curtis et al. · Vaccine · 2016 · 61 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of a cell culture-based quadrivalent influenza vaccine in adults: A Phase III, double-blind, multicenter, randomized, non-inferiority study

Stephan Bart, Kevin Cannon, Darrell T. Herrington et al. · Human Vaccines & Immunotherapeutics · 2016 · 57 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17